JPMorgan Chase & Co
ELV icon

JPMorgan Chase & Co’s Elevance Health ELV Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$573M Buy
1,473,707
+48,723
+3% +$19M 0.04% 364
2025
Q1
$620M Sell
1,424,984
-156,900
-10% -$68.2M 0.05% 317
2024
Q4
$584M Sell
1,581,884
-942,104
-37% -$348M 0.04% 324
2024
Q3
$1.31B Buy
2,523,988
+142,142
+6% +$73.9M 0.1% 190
2024
Q2
$1.29B Buy
2,381,846
+85,143
+4% +$46.1M 0.11% 178
2024
Q1
$1.19B Buy
2,296,703
+27,330
+1% +$14.2M 0.1% 189
2023
Q4
$1.07B Sell
2,269,373
-42,877
-2% -$20.2M 0.1% 186
2023
Q3
$1.01B Sell
2,312,250
-22,066
-0.9% -$9.61M 0.11% 185
2023
Q2
$1.04B Buy
2,334,316
+553,043
+31% +$246M 0.11% 180
2023
Q1
$819M Sell
1,781,273
-441,569
-20% -$203M 0.1% 202
2022
Q4
$1.14B Sell
2,222,842
-113,218
-5% -$58.1M 0.15% 145
2022
Q3
$1.06B Buy
2,336,060
+28,039
+1% +$12.7M 0.15% 139
2022
Q2
$1.11B Buy
2,308,021
+722,303
+46% +$349M 0.16% 138
2022
Q1
$779M Buy
1,585,718
+37,428
+2% +$18.4M 0.09% 206
2021
Q4
$718M Sell
1,548,290
-114,495
-7% -$53.1M 0.08% 229
2021
Q3
$620M Buy
1,662,785
+338,502
+26% +$126M 0.08% 252
2021
Q2
$506M Buy
1,324,283
+278,826
+27% +$106M 0.06% 318
2021
Q1
$375M Buy
1,045,457
+79,193
+8% +$28.4M 0.05% 354
2020
Q4
$310M Sell
966,264
-53,676
-5% -$17.2M 0.05% 372
2020
Q3
$265M Buy
1,019,940
+43,614
+4% +$11.3M 0.04% 372
2020
Q2
$257M Sell
976,326
-256,658
-21% -$67.5M 0.05% 350
2020
Q1
$280M Sell
1,232,984
-673,305
-35% -$153M 0.07% 275
2019
Q4
$576M Sell
1,906,289
-92,098
-5% -$27.8M 0.11% 189
2019
Q3
$480M Sell
1,998,387
-605,780
-23% -$145M 0.1% 217
2019
Q2
$735M Buy
2,604,167
+86,490
+3% +$24.4M 0.14% 147
2019
Q1
$723M Sell
2,517,677
-373,299
-13% -$107M 0.15% 141
2018
Q4
$759M Buy
2,890,976
+1,523,948
+111% +$400M 0.18% 125
2018
Q3
$375M Sell
1,367,028
-381,446
-22% -$105M 0.07% 269
2018
Q2
$416M Sell
1,748,474
-8,727
-0.5% -$2.08M 0.09% 235
2018
Q1
$386M Sell
1,757,201
-596,006
-25% -$131M 0.08% 246
2017
Q4
$529M Buy
2,353,207
+907,144
+63% +$204M 0.11% 195
2017
Q3
$274M Buy
1,446,063
+176,814
+14% +$33.6M 0.06% 311
2017
Q2
$239M Buy
1,269,249
+811,537
+177% +$153M 0.05% 337
2017
Q1
$75.7M Buy
457,712
+69,352
+18% +$11.5M 0.02% 668
2016
Q4
$55.8M Sell
388,360
-1,204,437
-76% -$173M 0.01% 760
2016
Q3
$200M Sell
1,592,797
-495,972
-24% -$62.2M 0.05% 344
2016
Q2
$274M Sell
2,088,769
-192,250
-8% -$25.3M 0.07% 287
2016
Q1
$317M Buy
2,281,019
+501,295
+28% +$69.7M 0.08% 257
2015
Q4
$248M Buy
1,779,724
+655,050
+58% +$91.3M 0.06% 310
2015
Q3
$157M Sell
1,124,674
-1,206,125
-52% -$169M 0.04% 403
2015
Q2
$383M Sell
2,330,799
-782,845
-25% -$128M 0.09% 241
2015
Q1
$481M Sell
3,113,644
-6,943
-0.2% -$1.07M 0.11% 200
2014
Q4
$392M Buy
3,120,587
+278,939
+10% +$35.1M 0.09% 250
2014
Q3
$340M Sell
2,841,648
-533,772
-16% -$63.8M 0.08% 269
2014
Q2
$363M Sell
3,375,420
-834,047
-20% -$89.8M 0.09% 239
2014
Q1
$419M Buy
4,209,467
+1,217,768
+41% +$121M 0.12% 192
2013
Q4
$276M Buy
2,991,699
+369,398
+14% +$34.1M 0.08% 269
2013
Q3
$219M Buy
2,622,301
+823,050
+46% +$68.8M 0.07% 302
2013
Q2
$147M Buy
+1,799,251
New +$147M 0.05% 371